Overview
Description
JMDC, Inc. engages in the provision of medical database and digital solutions to the healthcare sector. It operates through the following segments: Health Big Data, Telemedicine, and Dispensing Pharmacy Support. The Health Big Data segment deals with database construction, data analysis, health promotion, and medical cost control solutions. The Telemedicine segment provides digital solutions in areas related to diagnosis and treatment, including remote image diagnosis. The Dispensing Pharmacy Support segment offers electronic drug history and business systems for dispensing pharmacies. The company was founded on January 31, 2002 and is headquartered in Tokyo, Japan.
Healthcare Healthcare Services Healthcare Support Services Japan
Financials
Key metrics
Market capitalisation, EUR | 1,293.27 m |
EPS, EUR | 0.68 |
P/B ratio | 2.74 |
P/E ratio | 29.33 |
Dividend yield | 0.49% |
Income statement (2024)
Revenue, EUR | 255.25 m |
Net income, EUR | 35.61 m |
Profit margin | 13.95% |
What ETF is JMDC, Inc. in?
There are 33 ETFs which contain JMDC, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of JMDC, Inc. is the Global X Telemedicine & Digital Health UCITS ETF Dist GBP.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.